Healthcare BPO Market - 2025

March 2026 | 217 pages | ID: H0E0872A211FEN
DataM Intelligence

US$ 2,999.00 US$ 4,350.00 -31 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Healthcare BPO Market was valued at USD 260.45 billion in 2025 and is anticipated to reach by , at a CAGR of 0.11 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Healthcare BPO Market.

This report delivers a comprehensive overview of the Healthcare BPO Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Healthcare BPO Market. The Healthcare BPO Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2025–.

Healthcare BPO Market Scope:

By Payer Service
  • Human Resource Management
  • Claims Management
  • Customer Relationship Management (CRM)
  • Operational/Administrative Management
  • Care Management
  • Provider Management
  • Other Payer Services
By Provider Service
  • Patient Enrollment and Strategic Planning
  • Patient Care Service
  • Revenue Cycle Management
By Life Science Service
  • Research and Development
  • Manufacturing
  • Non-clinical Service
  • Supply Chain Management and Logistics
  • Sales and Marketing Services
  • Other Non-clinical Services
Key Players
  • Accenture
  • HCLTech Lifesciences Limited
  • GeBBS Healthcare Solutions
  • Genpact
  • International Business Machines Corporation (IBM)
  • Parexel International Corporation
  • IQVIA
  • Sutherland Global Services
  • United Health Group
  • Cognizant Technology Solutions
Major Highlights

This report delivers a comprehensive overview of the Healthcare BPO Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Healthcare BPO Market. The Healthcare BPO Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2025–.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:
  • North America (U.S., Canada, Mexico)
  • Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
  • Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
  • South America (Colombia, Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Partner Identification
  • Increase Your Customer Base by 3X using our Partner Identification tool
  • Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
  • Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
  • Prioritize partners by strategic fit rather than general capability.
Why Choose DataM?
  • Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
  • Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
  • White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
  • Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
  • Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
  • Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
Target Audience 2026
  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Snippet by Payer Service
3.2. Snippet by Provider Service
3.3. Snippet by Life Science Service
3.4. Snippet by Region

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Rapid Increase in Clinical Process Outsourcing (CPO)
  4.1.2. Restraints
    4.1.2.1. Challenges with healthcare BPO
  4.1.3. Opportunity
    4.1.3.1. Technological advancements
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis

6. COVID-19 ANALYSIS

6.1. Analysis of COVID-19
  6.1.1. Scenario Before COVID-19
  6.1.2. Scenario During COVID-19
  6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion

7. RUSSIA-UKRAINE WAR ANALYSIS

8. ARTIFICIAL INTELLIGENCE ANALYSIS

9. BY PAYER SERVICE

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Payer Service
  9.1.2. Market Attractiveness Index, By Payer Service
9.2. Human Resource Management*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Claims Management
  9.3.1. Claims Repricing
  9.3.2. Information Management Services
  9.3.3. Fraud Detection and Management
  9.3.4. Claims Investigation Services
  9.3.5. Claims Settlement Services
  9.3.6. Others
9.4. Customer Relationship Management (CRM)
9.5. Operational/Administrative Management
9.6. Care Management
9.7. Provider Management
9.8. Other Payer Services

10. BY PROVIDER SERVICE

10.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Provider Service
10.2. Market Attractiveness Index, By Provider Service
10.3. Patient Enrollment and Strategic Planning*
  10.3.1. Introduction
  10.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.4. Patient Care Service
  10.4.1. Device Monitoring
  10.4.2. Medical Imaging
  10.4.3. Medical Transcription
10.5. Revenue Cycle Management

11. BY LIFE SCIENCE SERVICE

11.1. Introduction
  11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Life Science Service
  11.1.2. Market Attractiveness Index, By Life Science Service
11.2. Research and Development*
  11.2.1. Introduction
  11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Manufacturing
11.4. Non-clinical Service
11.5. Supply Chain Management and Logistics
11.6. Sales and Marketing Services
  11.6.1. Marketing Services
  11.6.2. Research
  11.6.3. Analytics
  11.6.4. Forecasting
  11.6.5. Performance Reporting
11.7. Other Non-clinical Services

12. BY REGION

12.1. Introduction
  12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  12.1.2. Market Attractiveness Index, By Region
12.2. North America
  12.2.1. Introduction
  12.2.2. Key Region-Specific Dynamics
  12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Payer Service
  12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Provider Service
  12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Life Science Service
  12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.2.6.1. U.S.
    12.2.6.2. Canada
    12.2.6.3. Mexico
12.3. Europe
  12.3.1. Introduction
  12.3.2. Key Region-Specific Dynamics
  12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Payer Service
  12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Provider Service
  12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Life Science Service
  12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.3.6.1. Germany
    12.3.6.2. U.K.
    12.3.6.3. France
    12.3.6.4. Italy
    12.3.6.5. Spain
    12.3.6.6. Rest of Europe
12.4. South America
  12.4.1. Introduction
  12.4.2. Key Region-Specific Dynamics
  12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Payer Service
  12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Provider Service
  12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Life Science Service
  12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.4.6.1. Brazil
    12.4.6.2. Argentina
    12.4.6.3. Rest of South America
12.5. Asia-Pacific
  12.5.1. Introduction
  12.5.2. Key Region-Specific Dynamics
  12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Payer Service
  12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Provider Service
  12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Life Science Service
  12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.5.6.1. China
    12.5.6.2. India
    12.5.6.3. Japan
    12.5.6.4. Australia
    12.5.6.5. Rest of Asia-Pacific
12.6. Middle East and Africa
  12.6.1. Introduction
  12.6.2. Key Region-Specific Dynamics
  12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Payer Service
  12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Provider Service
  12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Life Science Service

13. COMPETITIVE LANDSCAPE

13.1. Competitive Scenario
13.2. Product Benchmarking
13.3. Company Share Analysis
13.4. Key Developments and Strategies

14. COMPANY PROFILES

14.1. Accenture*
  14.1.1. Company Overview
  14.1.2. Product Portfolio and Description
  14.1.3. Financial Overview
  14.1.4. Key Developments
14.2. HCLTech Lifesciences Limited
14.3. GeBBS Healthcare Solutions
14.4. Genpact
14.5. International Business Machines Corporation (IBM)
14.6. Parexel International Corporation
14.7. IQVIA
14.8. Sutherland Global Services
14.9. United Health Group
14.10. Cognizant Technology Solutions (*LIST NOT EXHAUSTIVE)

15. APPENDIX

15.1. About Us and Services
15.2. Contact Us


More Publications